Bio-Rad Laboratories, Inc., a Delaware Corporation, Cross v. Nicolet Instrument Corporation, a Wisconsin Corporation, Cross-Appellee

739 F.2d 604, 222 U.S.P.Q. (BNA) 654, 1984 U.S. App. LEXIS 15064
CourtCourt of Appeals for the Federal Circuit
DecidedJuly 12, 1984
DocketAppeal 83-829/83-864
StatusPublished
Cited by108 cases

This text of 739 F.2d 604 (Bio-Rad Laboratories, Inc., a Delaware Corporation, Cross v. Nicolet Instrument Corporation, a Wisconsin Corporation, Cross-Appellee) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bio-Rad Laboratories, Inc., a Delaware Corporation, Cross v. Nicolet Instrument Corporation, a Wisconsin Corporation, Cross-Appellee, 739 F.2d 604, 222 U.S.P.Q. (BNA) 654, 1984 U.S. App. LEXIS 15064 (Fed. Cir. 1984).

Opinion

BALDWIN, Circuit Judge.

This is an appeal from an unpublished decision of the United States District Court for the Northern District of California holding claims 1-7 of U.S. Patent No. 3,319,515 (hereinafter ’515 patent or Flournoy patent) for an “Interferometric Optical Phase Discrimination Apparatus” valid and infringed. Judgment was entered on a jury verdict rendered after fourty-four days of trial. We vacate the District Court’s denial of prejudgment interest and remand for an award of prejudgment interest or a determination that some reason exists for denying prejudgment interest. In all other respects, the judgment is affirmed.

The Parties

Bio-Rad Laboratories, Inc. (Bio-Rad) is a Delaware corporation with its principal office in Richmond, California. Between 1978 and 1979, Bio-Rad acquired two divisions, Digilab, Inc. (Digilab) and Block Engineering, Inc. (Block Engineering). Digilab was formed as a subsidiary of Block Engineering in 1969 to produce and sell instruments that rapidly measure the crystalline surface layer on semiconductors, known as the epitaxial layer. Since 1970, Digilab has manufactured and sold an epitaxial measuring instrument known as the FTG-12, under an exclusive license from E.I. du Pont de Nemours and Company (du Pont), owner of the ’515 patent. When Bio-Rad acquired Block Engineering and Digilab, it also acquired the exclusive license under the ’515 patent which included the right to enforce the patent against infringers. The name Bio-Rad will be used throughout this opinion to refer to the conduct of Digilab, and Block Engineering, as well as the conduct of Bio-Rad.

Nicolet Instrument Corporation (Nicolet) is a Wisconsin corporation engaged in the production and sale of electronic instruments. In 1979, Nicolet began selling an epitaxial thickness measuring instrument known as the MX-ECO.

Procedural Background

In 1981, Bio-Rad sued Nicolet for willful infringement of the ’515 patent by Nicolet’s production and sale of the MX-ECO measuring instrument. Nicolet counterclaimed for a declaratory judgment that the ’515 patent is invalid and not infringed, and for alleged violations of the antitrust laws.

Both Bio-Rad and Nicolet demanded a jury trial and 'agreed to submit the case to the jury on general verdicts without special interrogatories.' The jury declared all seven claims of the '515 patent valid and infringed, but not willfully infringed. The jury also concluded that Bio-Rad did not violate sections 1 or 2 of the Sherman Antitrust Act. The jury awarded Bio-Rad $3,078,000 in money damages for the infringement.

*607 Nicolet moved for judgment notwithstanding the verdict (JNOV) and, in the alternative, for a new trial. Nicolet also moved to deny enforcement of the ’515 patent for misuse. The district court denied all three motions and denied Bio-Rad’s separate request for prejudgment interest. The trial judge entered judgment on the jury verdicts without comment and permanently enjoined Nicolet from infringing the ’515 patent in any way, including by the production, use or sale of the MX-ECO epitaxial thickness gauge. Interest was awarded from the date judgment was entered.

Nicolet appeals from the judgment entered by the District Court, and from the court’s refusal to declare the ’515 patent unenforceable for patent misuse. Bio-Rad cross-appeals from the lower court’s denial of prejudgment interest. Although this appeal is from the judgment entered on the jury verdict, the District Court’s denial of Nicolet’s motions guides our analysis. Accordingly, we consider the issues raised by the parties in the following order:

I. Grounds For JNOV.
II. Grounds For New Trial.
III. Patent Misuse.
IV. Prejudgment Interest.

Standard of Review

Several cases have issued from this court describing the analysis trial judges should follow when they entertain motions for JNOV or new trial. Connell v. Sears, Roebuck & Co., 722 F.2d 1542, 1546, 220 USPQ 193, 197 (Fed.Cir.1983); Railroad Dynamics, Inc. v. A. Stucki Co., 727 F.2d 1506, 1512-13, 220 USPQ 929, 936 (Fed.Cir. 1984); Perkin-Elmer Corp. v. Computervision Corp., 732 F.2d 888, 221 USPQ 669, 672-673 (Fed.Cir.1984). That analysis need not be repeated here, but description of our appellate review process is useful.

Nicolet has urged that we review the record de novo, in part because no interrogatories were submitted to the jury and because the trial judge did not produce a written opinion discussing reasons for denying Nicolet’s motions or describing the facts supporting the jury verdict. Nicolet mistakes our role. The presence of special interrogatories or a written opinion by the trial court certainly makes our task easier but the absence of these aids does not alter our standard of review. In the absence of special interrogatories we presume the existence of factual findings and legal conclusions necessary to support the verdict reached by the jury. The findings and conclusions are controlled by the court’s instructions to the jury. Perkin-Elmer, 732 F.2d at 893, 221 USPQ at 673. On appeal after denial of a motion for JNOV, appellant must show either: 1) that the jury’s presumed or express findings are not supported by substantial evidence or, 2) if the jury’s findings were supported by substantial evidence, that the legal conclusions implied from the verdict cannot be supported by those findings. Perkin-Elmer, 732 F.2d at 893, 221 USPQ at 673. In sum, appellant must show either that reasonable jurors could not have made the presumed findings or that the conclusions necessary to the general verdict were not supported. The' District Court’s denial of Nicolet’s Motion for a new trial is reviewed on an abuse of discretion standard. Railroad Dynamics, Inc. v. A. Stucki Co., 727 F.2d at 1512, 220 USPQ at 935. As this description of our approach demonstrates, our role as a reviewing court is circumscribed by standards that place a difficult burden on appellant.

Analysis

I. Grounds For JNOV

To overturn the District Court’s denial of the Motion For JNOV, Nicolet presents several grounds for declaring the ’515 patent invalid. The various grounds for invalidity will be discussed under the following lettered sections:

A. Anticipation and Obviousness.
B. Fraud.
C. Compliance With The Requirements Of 35 U.S.C. § 112.
D. Infringement.

*608 A. Anticipation and Obviousness

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Z4 Technologies, Inc. v. Microsoft Corp.
507 F.3d 1340 (Federal Circuit, 2007)
Ricoh v. Nashua Corporation
D. New Hampshire, 1998
Joy Technologies, Inc. v. Flakt, Inc.
954 F. Supp. 796 (D. Delaware, 1996)
Donnelly Corp. v. Gentex Corp.
918 F. Supp. 1126 (W.D. Michigan, 1996)
Fonar Corp. v. General Electric Co.
902 F. Supp. 330 (E.D. New York, 1995)
General American Transportation Corp. v. Cryo-Trans, Inc.
893 F. Supp. 774 (N.D. Illinois, 1995)
Schneider (Europe) AG v. SciMed Life Systems, Inc.
852 F. Supp. 813 (D. Minnesota, 1994)
American Medical Systems, Inc. v. Medical Engineering Corp.
794 F. Supp. 1370 (E.D. Wisconsin, 1992)
Pall Corp. v. Micron Separations, Inc.
792 F. Supp. 1298 (D. Massachusetts, 1992)
Goodwall Construction Co. v. Beers Construction Co.
824 F. Supp. 1044 (N.D. Georgia, 1992)
Scripto-Tokai Corp. v. Gillette Co.
788 F. Supp. 439 (C.D. California, 1992)
Rite-Hite Corp. v. Kelley Co., Inc.
774 F. Supp. 1514 (E.D. Wisconsin, 1991)
Biodex Corporation v. Loredan Biomedical, Inc.
946 F.2d 850 (Federal Circuit, 1991)
Micro Motion, Inc. v. Exac Corp.
761 F. Supp. 1420 (N.D. California, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
739 F.2d 604, 222 U.S.P.Q. (BNA) 654, 1984 U.S. App. LEXIS 15064, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bio-rad-laboratories-inc-a-delaware-corporation-cross-v-nicolet-cafc-1984.